The Dubai Health Authority (DHA) on Tuesday announced it was approving a longer interval period between doses for the Oxford-AstraZeneca Covid vaccine.
"Based on recent studies from the University of Oxford on the Oxford-AstraZeneca vaccine and as per the recommendations of the WHO, DHA has approved a 10-week interval between the 1st & 2nd dose of the Oxford-AstraZeneca vaccine," the authority said in a post published on its official social media account.
Based on recent studies from the University of Oxford on the Oxford-AstraZeneca vaccine and as per the recommendations of the WHO, DHA has approved a 10-week interval between the 1st & 2nd dose of the Oxford-AstraZeneca vaccine.
Recent studies showed a higher efficacy and higher acquired immunity when the dosing interval between the first and second doses was increased, it explained.
"All those who are due for the second dose of this vaccine will receive a text message with the date and location for their vaccination appointment," it added.
On February 2, the UAE announced it would start offering the India-made AstraZeneca Covid-19 vaccines as part of its national vaccination programme.
It is the fourth vaccine being offered in the UAE, apart from Sinopharm, Pfizer-BioNTech, and Sputnik V.
Khaleej Times: Copyright © 2017 Khaleej Times. All Rights Reserved. Provided by SyndiGate Media Inc. ( www.Syndigate.info).
Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.